Dapagliflozin effect on cause-specific mortality in patients with heart failure: Pooed analysis of DAPA-hF and DELIVER trial.


eMediNexus    30 January 2023


Reference-Desai AS, Jhund PS, Claggett BL, et al. Effect of Dapagliflozin on Cause-Specific Mortality in Patients With Heart Failure Across the Spectrum of Ejection Fraction: A Participant-Level Pooled Analysis of DAPA-HF and DELIVER. JAMA Cardiol. 2022;7(12):1227–1234. doi:10.1001/jamacardio.2022.3736

To comment on this article,
create a free account.

Sign Up to instantly get access to 10000+ Articles & 1000+ Cases

Already registered?

Login Now

Most Popular Articles

News and Updates

eMediNexus provides latest updates on medical news, medical case studies from India. In-depth medical case studies and research designed for doctors and healthcare professionals.